img

Global Recombinant Peptide Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Recombinant Peptide Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

A recombinant peptide therapy is produced through recombinant DNA technology. This involves inserting the DNA encoding the peptide into bacterial or mammalian cells, expressing the peptide in these cells and then purifying it from them.
Recombinant Peptide report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Recombinant Peptide market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Oncology and Blood Disorders are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Recombinant Peptide industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Recombinant Peptide key manufacturers include Sandoz Pharma, Stada Arzneimittel, Amgen, Hospira, Actavis, Cipla Ltd., Wockhardt Ltd. and Biocon Ltd., etc. Sandoz Pharma, Stada Arzneimittel, Amgen are top 3 players and held % sales share in total in 2022.
Recombinant Peptide can be divided into Glucagon, Calcitonin and Other,, etc. Glucagon is the mainstream product in the market, accounting for % sales share globally in 2022.
Recombinant Peptide is widely used in various fields, such as Oncology, Blood Disorders, Infectious Diseases and Autoimmune Diseases, etc. Oncology provides greatest supports to the Recombinant Peptide industry development. In 2022, global % sales of Recombinant Peptide went into Oncology filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Recombinant Peptide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sandoz Pharma
Stada Arzneimittel
Amgen
Hospira
Actavis
Cipla Ltd.
Wockhardt Ltd.
Biocon Ltd.
Segment by Type
Glucagon
Calcitonin
Other

Segment by Application


Oncology
Blood Disorders
Infectious Diseases
Autoimmune Diseases
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Recombinant Peptide market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Recombinant Peptide, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Recombinant Peptide industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Recombinant Peptide in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Recombinant Peptide introduction, etc. Recombinant Peptide Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Recombinant Peptide market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Recombinant Peptide Market Overview
1.1 Recombinant Peptide Product Overview
1.2 Recombinant Peptide Market Segment by Type
1.2.1 Glucagon
1.2.2 Calcitonin
1.2.3 Other
1.3 Global Recombinant Peptide Market Size by Type
1.3.1 Global Recombinant Peptide Market Size Overview by Type (2018-2034)
1.3.2 Global Recombinant Peptide Historic Market Size Review by Type (2018-2024)
1.3.3 Global Recombinant Peptide Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Recombinant Peptide Sales Breakdown by Type (2018-2024)
1.4.2 Europe Recombinant Peptide Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Recombinant Peptide Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Recombinant Peptide Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Recombinant Peptide Sales Breakdown by Type (2018-2024)
2 Global Recombinant Peptide Market Competition by Company
2.1 Global Top Players by Recombinant Peptide Sales (2018-2024)
2.2 Global Top Players by Recombinant Peptide Revenue (2018-2024)
2.3 Global Top Players by Recombinant Peptide Price (2018-2024)
2.4 Global Top Manufacturers Recombinant Peptide Manufacturing Base Distribution, Sales Area, Product Type
2.5 Recombinant Peptide Market Competitive Situation and Trends
2.5.1 Recombinant Peptide Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Recombinant Peptide Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Peptide as of 2022)
2.7 Date of Key Manufacturers Enter into Recombinant Peptide Market
2.8 Key Manufacturers Recombinant Peptide Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Recombinant Peptide Status and Outlook by Region
3.1 Global Recombinant Peptide Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Recombinant Peptide Historic Market Size by Region
3.2.1 Global Recombinant Peptide Sales in Volume by Region (2018-2024)
3.2.2 Global Recombinant Peptide Sales in Value by Region (2018-2024)
3.2.3 Global Recombinant Peptide Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Recombinant Peptide Forecasted Market Size by Region
3.3.1 Global Recombinant Peptide Sales in Volume by Region (2024-2034)
3.3.2 Global Recombinant Peptide Sales in Value by Region (2024-2034)
3.3.3 Global Recombinant Peptide Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Recombinant Peptide by Application
4.1 Recombinant Peptide Market Segment by Application
4.1.1 Oncology
4.1.2 Blood Disorders
4.1.3 Infectious Diseases
4.1.4 Autoimmune Diseases
4.1.5 Other
4.2 Global Recombinant Peptide Market Size by Application
4.2.1 Global Recombinant Peptide Market Size Overview by Application (2018-2034)
4.2.2 Global Recombinant Peptide Historic Market Size Review by Application (2018-2024)
4.2.3 Global Recombinant Peptide Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Recombinant Peptide Sales Breakdown by Application (2018-2024)
4.3.2 Europe Recombinant Peptide Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Recombinant Peptide Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Recombinant Peptide Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Recombinant Peptide Sales Breakdown by Application (2018-2024)
5 North America Recombinant Peptide by Country
5.1 North America Recombinant Peptide Historic Market Size by Country
5.1.1 North America Recombinant Peptide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Recombinant Peptide Sales in Volume by Country (2018-2024)
5.1.3 North America Recombinant Peptide Sales in Value by Country (2018-2024)
5.2 North America Recombinant Peptide Forecasted Market Size by Country
5.2.1 North America Recombinant Peptide Sales in Volume by Country (2024-2034)
5.2.2 North America Recombinant Peptide Sales in Value by Country (2024-2034)
6 Europe Recombinant Peptide by Country
6.1 Europe Recombinant Peptide Historic Market Size by Country
6.1.1 Europe Recombinant Peptide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Recombinant Peptide Sales in Volume by Country (2018-2024)
6.1.3 Europe Recombinant Peptide Sales in Value by Country (2018-2024)
6.2 Europe Recombinant Peptide Forecasted Market Size by Country
6.2.1 Europe Recombinant Peptide Sales in Volume by Country (2024-2034)
6.2.2 Europe Recombinant Peptide Sales in Value by Country (2024-2034)
7 Asia-Pacific Recombinant Peptide by Region
7.1 Asia-Pacific Recombinant Peptide Historic Market Size by Region
7.1.1 Asia-Pacific Recombinant Peptide Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Recombinant Peptide Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Recombinant Peptide Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Recombinant Peptide Forecasted Market Size by Region
7.2.1 Asia-Pacific Recombinant Peptide Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Recombinant Peptide Sales in Value by Region (2024-2034)
8 Latin America Recombinant Peptide by Country
8.1 Latin America Recombinant Peptide Historic Market Size by Country
8.1.1 Latin America Recombinant Peptide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Recombinant Peptide Sales in Volume by Country (2018-2024)
8.1.3 Latin America Recombinant Peptide Sales in Value by Country (2018-2024)
8.2 Latin America Recombinant Peptide Forecasted Market Size by Country
8.2.1 Latin America Recombinant Peptide Sales in Volume by Country (2024-2034)
8.2.2 Latin America Recombinant Peptide Sales in Value by Country (2024-2034)
9 Middle East and Africa Recombinant Peptide by Country
9.1 Middle East and Africa Recombinant Peptide Historic Market Size by Country
9.1.1 Middle East and Africa Recombinant Peptide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Recombinant Peptide Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Recombinant Peptide Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Recombinant Peptide Forecasted Market Size by Country
9.2.1 Middle East and Africa Recombinant Peptide Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Recombinant Peptide Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Sandoz Pharma
10.1.1 Sandoz Pharma Company Information
10.1.2 Sandoz Pharma Introduction and Business Overview
10.1.3 Sandoz Pharma Recombinant Peptide Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sandoz Pharma Recombinant Peptide Products Offered
10.1.5 Sandoz Pharma Recent Development
10.2 Stada Arzneimittel
10.2.1 Stada Arzneimittel Company Information
10.2.2 Stada Arzneimittel Introduction and Business Overview
10.2.3 Stada Arzneimittel Recombinant Peptide Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Stada Arzneimittel Recombinant Peptide Products Offered
10.2.5 Stada Arzneimittel Recent Development
10.3 Amgen
10.3.1 Amgen Company Information
10.3.2 Amgen Introduction and Business Overview
10.3.3 Amgen Recombinant Peptide Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Amgen Recombinant Peptide Products Offered
10.3.5 Amgen Recent Development
10.4 Hospira
10.4.1 Hospira Company Information
10.4.2 Hospira Introduction and Business Overview
10.4.3 Hospira Recombinant Peptide Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Hospira Recombinant Peptide Products Offered
10.4.5 Hospira Recent Development
10.5 Actavis
10.5.1 Actavis Company Information
10.5.2 Actavis Introduction and Business Overview
10.5.3 Actavis Recombinant Peptide Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Actavis Recombinant Peptide Products Offered
10.5.5 Actavis Recent Development
10.6 Cipla Ltd.
10.6.1 Cipla Ltd. Company Information
10.6.2 Cipla Ltd. Introduction and Business Overview
10.6.3 Cipla Ltd. Recombinant Peptide Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Cipla Ltd. Recombinant Peptide Products Offered
10.6.5 Cipla Ltd. Recent Development
10.7 Wockhardt Ltd.
10.7.1 Wockhardt Ltd. Company Information
10.7.2 Wockhardt Ltd. Introduction and Business Overview
10.7.3 Wockhardt Ltd. Recombinant Peptide Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Wockhardt Ltd. Recombinant Peptide Products Offered
10.7.5 Wockhardt Ltd. Recent Development
10.8 Biocon Ltd.
10.8.1 Biocon Ltd. Company Information
10.8.2 Biocon Ltd. Introduction and Business Overview
10.8.3 Biocon Ltd. Recombinant Peptide Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Biocon Ltd. Recombinant Peptide Products Offered
10.8.5 Biocon Ltd. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Recombinant Peptide Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Recombinant Peptide Industrial Chain Analysis
11.4 Recombinant Peptide Market Dynamics
11.4.1 Recombinant Peptide Industry Trends
11.4.2 Recombinant Peptide Market Drivers
11.4.3 Recombinant Peptide Market Challenges
11.4.4 Recombinant Peptide Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Recombinant Peptide Distributors
12.3 Recombinant Peptide Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Glucagon
Table 2. Major Company of Calcitonin
Table 3. Major Company of Other
Table 4. Global Recombinant Peptide Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Recombinant Peptide Sales by Type (2018-2024) & (K Units)
Table 6. Global Recombinant Peptide Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Recombinant Peptide Sales by Type (2018-2024) & (US& Million)
Table 8. Global Recombinant Peptide Market Share in Value by Type (2018-2024)
Table 9. Global Recombinant Peptide Price by Type (2018-2024) & (US$/Unit)
Table 10. Global Recombinant Peptide Sales by Type (2024-2034) & (K Units)
Table 11. Global Recombinant Peptide Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Recombinant Peptide Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Recombinant Peptide Sales Market Share in Value by Type (2024-2034)
Table 14. Global Recombinant Peptide Price by Type (2024-2034) & (US$/Unit)
Table 15. North America Recombinant Peptide Sales by Type (2018-2024) & (K Units)
Table 16. North America Recombinant Peptide Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Recombinant Peptide Sales (K Units) by Type (2018-2024)
Table 18. Europe Recombinant Peptide Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Recombinant Peptide Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Recombinant Peptide Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Recombinant Peptide Sales (K Units) by Type (2018-2024)
Table 22. Latin America Recombinant Peptide Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Recombinant Peptide Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Recombinant Peptide Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Recombinant Peptide Sales by Company (2018-2024) & (K Units)
Table 26. Global Recombinant Peptide Sales Share by Company (2018-2024)
Table 27. Global Recombinant Peptide Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Recombinant Peptide Revenue Share by Company (2018-2024)
Table 29. Global Market Recombinant Peptide Price by Company (2018-2024) & (US$/Unit)
Table 30. Global Recombinant Peptide Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Recombinant Peptide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Peptide as of 2022)
Table 33. Date of Key Manufacturers Enter into Recombinant Peptide Market
Table 34. Key Manufacturers Recombinant Peptide Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Recombinant Peptide Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Recombinant Peptide Sales by Region (2018-2024) & (K Units)
Table 38. Global Recombinant Peptide Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Recombinant Peptide Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Recombinant Peptide Sales Market Share in Value by Region (2018-2024)
Table 41. Global Recombinant Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global Recombinant Peptide Sales by Region (2024-2034) & (K Units)
Table 43. Global Recombinant Peptide Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Recombinant Peptide Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Recombinant Peptide Sales Market Share in Value by Region (2024-2034)
Table 46. Global Recombinant Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 47. Global Recombinant Peptide Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Recombinant Peptide Sales by Application (2018-2024) & (K Units)
Table 49. Global Recombinant Peptide Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Recombinant Peptide Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Recombinant Peptide Sales Market Share in Value by Application (2018-2024)
Table 52. Global Recombinant Peptide Price by Application (2018-2024) & (US$/Unit)
Table 53. Global Recombinant Peptide Sales by Application (2024-2034) & (K Units)
Table 54. Global Recombinant Peptide Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Recombinant Peptide Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Recombinant Peptide Sales Market Share in Value by Application (2024-2034)
Table 57. Global Recombinant Peptide Price by Application (2024-2034) & (US$/Unit)
Table 58. North America Recombinant Peptide Sales by Application (2018-2024) (K Units)
Table 59. North America Recombinant Peptide Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Recombinant Peptide Sales by Application (2018-2024) (K Units)
Table 61. Europe Recombinant Peptide Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Recombinant Peptide Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Recombinant Peptide Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Recombinant Peptide Sales by Application (2018-2024) (K Units)
Table 65. Latin America Recombinant Peptide Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Recombinant Peptide Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Recombinant Peptide Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Recombinant Peptide Sales by Country (2018-2024) & (K Units)
Table 69. North America Recombinant Peptide Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Recombinant Peptide Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Recombinant Peptide Sales Market Share in Value by Country (2018-2024)
Table 72. North America Recombinant Peptide Sales by Country (2024-2034) & (K Units)
Table 73. North America Recombinant Peptide Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Recombinant Peptide Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Recombinant Peptide Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Recombinant Peptide Sales by Country (2018-2024) & (K Units)
Table 77. Europe Recombinant Peptide Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Recombinant Peptide Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Recombinant Peptide Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Recombinant Peptide Sales by Country (2024-2034) & (K Units)
Table 81. Europe Recombinant Peptide Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Recombinant Peptide Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Recombinant Peptide Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Recombinant Peptide Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Recombinant Peptide Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Recombinant Peptide Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Recombinant Peptide Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Recombinant Peptide Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Recombinant Peptide Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Recombinant Peptide Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Recombinant Peptide Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Recombinant Peptide Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Recombinant Peptide Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Recombinant Peptide Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Recombinant Peptide Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Recombinant Peptide Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Recombinant Peptide Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Recombinant Peptide Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Recombinant Peptide Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Recombinant Peptide Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Recombinant Peptide Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Recombinant Peptide Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Recombinant Peptide Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Recombinant Peptide Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Recombinant Peptide Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Recombinant Peptide Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Recombinant Peptide Sales Market Share in Value by Country (2024-2034)
Table 108. Sandoz Pharma Company Information
Table 109. Sandoz Pharma Introduction and Business Overview
Table 110. Sandoz Pharma Recombinant Peptide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Sandoz Pharma Recombinant Peptide Product
Table 112. Sandoz Pharma Recent Development
Table 113. Stada Arzneimittel Company Information
Table 114. Stada Arzneimittel Introduction and Business Overview
Table 115. Stada Arzneimittel Recombinant Peptide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Stada Arzneimittel Recombinant Peptide Product
Table 117. Stada Arzneimittel Recent Development
Table 118. Amgen Company Information
Table 119. Amgen Introduction and Business Overview
Table 120. Amgen Recombinant Peptide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Amgen Recombinant Peptide Product
Table 122. Amgen Recent Development
Table 123. Hospira Company Information
Table 124. Hospira Introduction and Business Overview
Table 125. Hospira Recombinant Peptide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Hospira Recombinant Peptide Product
Table 127. Hospira Recent Development
Table 128. Actavis Company Information
Table 129. Actavis Introduction and Business Overview
Table 130. Actavis Recombinant Peptide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Actavis Recombinant Peptide Product
Table 132. Actavis Recent Development
Table 133. Cipla Ltd. Company Information
Table 134. Cipla Ltd. Introduction and Business Overview
Table 135. Cipla Ltd. Recombinant Peptide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Cipla Ltd. Recombinant Peptide Product
Table 137. Cipla Ltd. Recent Development
Table 138. Wockhardt Ltd. Company Information
Table 139. Wockhardt Ltd. Introduction and Business Overview
Table 140. Wockhardt Ltd. Recombinant Peptide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Wockhardt Ltd. Recombinant Peptide Product
Table 142. Wockhardt Ltd. Recent Development
Table 143. Biocon Ltd. Company Information
Table 144. Biocon Ltd. Introduction and Business Overview
Table 145. Biocon Ltd. Recombinant Peptide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Biocon Ltd. Recombinant Peptide Product
Table 147. Biocon Ltd. Recent Development
Table 148. Key Raw Materials Lists
Table 149. Raw Materials Key Suppliers Lists
Table 150. Recombinant Peptide Market Trends
Table 151. Recombinant Peptide Market Drivers
Table 152. Recombinant Peptide Market Challenges
Table 153. Recombinant Peptide Market Restraints
Table 154. Recombinant Peptide Distributors List
Table 155. Recombinant Peptide Downstream Customers
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Peptide Product Picture
Figure 2. Global Recombinant Peptide Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Recombinant Peptide Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Recombinant Peptide Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Glucagon
Figure 6. Global Glucagon Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Calcitonin
Figure 8. Global Calcitonin Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Other
Figure 10. Global Other Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global Recombinant Peptide Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Recombinant Peptide Sales Market Share by Type in 2022 & 2034
Figure 13. North America Recombinant Peptide Sales Market Share in Volume by Type in 2022
Figure 14. North America Recombinant Peptide Sales Market Share in Value by Type in 2022
Figure 15. Europe Recombinant Peptide Sales Market Share in Volume by Type in 2022
Figure 16. Europe Recombinant Peptide Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Recombinant Peptide Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Recombinant Peptide Sales Market Share in Value by Type in 2022
Figure 19. Latin America Recombinant Peptide Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Recombinant Peptide Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Recombinant Peptide Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Recombinant Peptide Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Peptide Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Peptide Revenue in 2022
Figure 25. Recombinant Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Oncology
Figure 27. Global Oncology Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Blood Disorders
Figure 29. Global Blood Disorders Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Infectious Diseases
Figure 31. Global Infectious Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Autoimmune Diseases
Figure 33. Global Autoimmune Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Other
Figure 35. Global Other Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Global Recombinant Peptide Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Recombinant Peptide Sales Market Share by Application in 2022 & 2034
Figure 38. North America Recombinant Peptide Sales Market Share in Volume by Application in 2022
Figure 39. North America Recombinant Peptide Sales Market Share in Value by Application in 2022
Figure 40. Europe Recombinant Peptide Sales Market Share in Volume by Application in 2022
Figure 41. Europe Recombinant Peptide Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Recombinant Peptide Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Recombinant Peptide Sales Market Share in Value by Application in 2022
Figure 44. Latin America Recombinant Peptide Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Recombinant Peptide Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Recombinant Peptide Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Recombinant Peptide Manufacturing Cost Structure
Figure 49. Recombinant Peptide Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries